GVAX vaccine, or allogenic, whole pancreatic cancer cells modified to express granulocyte-macrophage colony-stimulating factor (GM-CSF), sometimes given with cyclophosphamide to deplete Tregs, has been shown to induce T-cell infiltration in the PDAC TME [141,162]. The gene discussed is CSF2; the disease is familial pancreatic carcinoma.